Full Press Release Details
CAMBRIDGE, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will participate in the following upcoming healthcare conferences in June:
Tuesday, June 4, 2019
Jefferies Healthcare Conference
Location: New York, NY
Tuesday, June 18, 2019
Raymond James Life Sciences and MedTech Conference
Location: New York, NY
A live webcast of Intellia’s presentation at the Raymond James Conference will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcast, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Intellia’s website for approximately 14 days following the conference.
About Intellia Therapeutics
Senior Manager, Investor Relations
Jennifer Mound Smoter